Skip to main content
23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
3.270
+0.210 (6.86%)
At close: Dec 20, 2024, 4:00 PM
3.180
-0.090 (-2.75%)
After-hours: Dec 20, 2024, 4:44 PM EST

23andMe Holding Co. Revenue

23andMe Holding Co. had revenue of $44.07M in the quarter ending September 30, 2024, a decrease of -11.86%. This brings the company's revenue in the last twelve months to $193.26M, down -28.47% year-over-year. In the fiscal year ending March 31, 2024, 23andMe Holding Co. had annual revenue of $219.64M, down -26.66%.

Revenue (ttm)
$193.26M
Revenue Growth
-28.47%
P/S Ratio
0.42
Revenue / Employee
$332,062
Employees
582
Market Cap
84.49M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024219.64M-79.85M-26.66%
Mar 31, 2023299.49M27.60M10.15%
Mar 31, 2022271.89M27.97M11.47%
Mar 31, 2021243.92M-61.54M-20.15%
Mar 31, 2020305.46M-135.44M-30.72%
Mar 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
So-Young International 212.14M
Karyopharm Therapeutics 148.44M
Assertio Holdings 125.76M
InspireMD 6.82M
Adlai Nortye 5.00M
I-Mab 3.31M
Ikena Oncology 659.00K
Entera Bio 99.00K
Revenue Rankings

ME News

More News